Health Care/Hospital

LightingWay Counselling Offers Affordable Therapy Amid Rising Job Market Uncertainty in Singapore

SINGAPORE, Dec. 17, 2025 /PRNewswire/ -- Recent employment data reveals heightened job market pressures affecting mental health needs. In light of these circumstances, LightingWay Counselling & Therapy continues to provide affordable therapy services to help Singaporeans cope better with a comple...

2025-12-17 14:00 3117

BioTec Sets New Market Standards with Fusion-Based Bio Solutions, Aiming for Global Expansion

SEOUL, South Korea, Dec. 16, 2025 /PRNewswire/ -- BioTec's new releases are attracting attention as technology-fusion solutions rarely seen in the current market. The company's supplement developed with processed sulfur and microbial fermentation offers improved gut health and immune support for ...

2025-12-17 12:10 1500

3 in 4 Asia Pacific Entrepreneurs Anticipate Economic Gains Next Year - Herbalife Survey

HONG KONG, Dec. 17, 2025 /PRNewswire/ -- Herbalife, a premier health and wellness company, community and platform, today released findings from itsAsia Pacific (APAC) Health and Economic Empowerment Survey 2025. The findings revealed strong economic optimism among entrepreneurs, with three in fou...

2025-12-17 11:00 7009

Robotware.ai Advances AI Poultry Disease Detection PoC in Malaysia with SDEC

KUALA LUMPUR, Malaysia, Dec. 17, 2025 /PRNewswire/ -- Robotware.ai , a Korea-based artificial intelligence company specializing in livestock intelligence solutions, is advancing itsproof-of-concept (PoC) deployment in Malaysia in collaboration with Sarawak Digital Economy Corporation (SDEC) , ...

2025-12-17 09:00 2204

Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma

SHANGHAI and HONG KONG, Dec. 17, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2025-12-17 09:00 1835

Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery

ADELAIDE, Australia, Dec. 17, 2025 /PRNewswire/ -- Australian company Ferronova has raised a further$6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of cancer cells and reduce the risk of undetected recurrence fol...

2025-12-17 08:30 1759

Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies

SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, Dec. 16, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced amulti-year, global strategi...

2025-12-17 08:04 1483

Jiaying Pharmaceutical: A New Pathway for the Industrialization of Century-Old Hakka Medicine

HONG KONG, Dec. 17, 2025 /PRNewswire/ -- Recently, Meizhou in Guangdong, known as the "World Capital of the Hakka", welcomed a globally watched event, the Seventh World Hakka Entrepreneurs Convention. At this gathering that drew the attention of Hakka entrepreneurs worldwide, Guangdong Jiaying Ph...

2025-12-17 08:00 1252

All CONEC Signs MOU with MINIMAX, Taking First Step in Standardizing Digital Implant Production

SEOUL, South Korea, Dec. 17, 2025 /PRNewswire/ -- All CONEC has signed a memorandum of understanding (MOU) with Australian digital dental company MINIMAX to establish a collaborative framework for digital implant production and lay the groundwork for overseas market entry. Digital implant produc...

2025-12-17 06:00 929

Leaders Dental Unveils Vision to Become "The Central Hub of the Digital Dentistry Ecosystem," Accelerates AI and IoT-Driven Production Automation

SEOUL, South Korea, Dec. 17, 2025 /PRNewswire/ -- Leaders Dental Laboratory, a leading force in Korea's digital dental technology sector, has announced a new vision to position itself as "the central hub of the digital dentistry ecosystem." To realize this vision, the company is making significan...

2025-12-17 06:00 763

The World's First AI Orchestrator Data Platform for Healthcare Launches

Orchestral – a Pioneering AI Orchestrator Data Platform Built for Healthcare AUCKLAND, New Zealand, Dec. 16, 2025 /PRNewswire/ -- McCrae Tech has launched the world's first health AI orchestrator. The product, called Orchestral , is a health-native AI orchestrator dat...

2025-12-17 02:00 1640

KPM Analytics Unveils the SmartChem® 800 Series, a Next-Generation Platform for High-Throughput Wet Chemistry

Industry's highest-capacity discrete analyzer delivers true walk-away automation for commercial laboratories WESTBOROUGH, Mass., Dec. 16, 2025 /PRNewswire/ -- Commercial laboratories face mounting pressure to process more samples with fewer staff while maintaining fast turnaround times. When urg...

2025-12-16 22:00 1706

Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development

* The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with strong backing from both new investors and existing supporters * Proceeds to advance two differentiated and highly competitive ADC programs in global Phase I trials ...

2025-12-16 21:30 1686

Breakthrough Progress: METiS TechBio Publishes Consecutive Research Findings in Nature Communications and the Journal for ImmunoTherapy of Cancer

BEIJING, Dec. 16, 2025 /PRNewswire/ -- METiS TechBio ("METiS") today announced that two of its oncology pipeline candidates,MTS-105 and MTS-107, have been published in leading international peer-reviewed journals,Nature Communications and theJournal for ImmunoTherapy of Cancer (JITC), representin...

2025-12-16 18:59 1649

Breaking the "Untreatable": Biostar Pharma's UTD1 Achieves First Patient Dosing in U.S. for Pivotal Clinical Trial for Breast Cancer Brain Metastases

SAN FRANCISCO, Dec. 15, 2025 /PRNewswire/ -- Biostar Pharma, Inc., the U.S. wholly-owned subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Stock Cod e: 2563.HK), today announced that the first patient has been dosed for one of its key oversea clinical studies: the U.S. pivotal clinical stud...

2025-12-16 12:55 1792

Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development

* The company secured $47 million through extension rounds of Series A led by Legend Capital and Meituan Long-Z Investment with strong backing from both new investors and existing supporters * Proceeds to advance two differentiated and highly competitive ADC programs in global Phase I trials ...

2025-12-16 08:30 1841

Perennial Healthcare City Launched Adjacent to Chongqing East HSR Station, Western China's Largest HSR Hub

* Establishment of new healthcare gateway in Chongqing amid the 10th anniversary of the Chongqing Connectivity Initiative and as part of the 35th anniversary celebration ofSingapore-China diplomatic relations; * Maiden investment in Chongqing marks Perennial Holdings' sixth healthcare-centric...

2025-12-16 07:05 3245

Enginprime Medical Inc Announces First-in-Human Study of Its Leading OpusOne™ pVAD

HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ -- Enginprime Medical Inc ("Enginprime"), an emerging leader in percutaneous ventricular assist device (pVAD) technologies and a Voyagers Capital portfolio company, today announced that its industry leading pVAD, OpusOne™, has entered its first-in-human...

2025-12-16 06:00 1800

Miroma Project Factory: Powers Clinical-Grade App for One of Australia's Largest Smoking Cessation Trials

SYDNEY, Dec. 16, 2025 /PRNewswire/ -- Miroma Project Factory (MPF) has delivered a bespoke mobile solution for Screen2Quit, part of the International Lung Study trial and one of Australia's most ambitious research studies targeting smoking cessation in people ...

2025-12-16 05:07 2190

HitGen Submits Commitment Letter to Science Based Targets initiative (SBTi)

CHENGDU, China, Dec. 15, 2025 /PRNewswire/ -- HitGen Inc. (hereinafter referred to as "HitGen", SSE: 688222.SH), announced it has officially submitted its commitment letter to the Science Based Targets initiative (SBTi). HitGen has pledged to set near-term science-based targets within the next tw...

2025-12-15 22:30 1998
1 ... 22232425262728 ... 858